DNA microarray analysis using a smartphone to detect the BRCA-1 gene.

Area of Science:

• Biotechnology
• Nanotechnology
• Medical Diagnostics

Background:

• DNA microarrays analyze gene expression via fluorescently labeled complementary DNAs (cDNAs).
• A key limitation for microarray implementation in resource-limited settings is the lack of accessible detection instruments for image generation.
• Existing point-of-care disease detection methods often lack the capability to capture standard microarray images.

Purpose of the Study:

• To develop a portable, smartphone-connected fluorescence microarray imaging system.
• To enable sensitive detection of breast cancer gene expression (BRCA-1) using microarray technology.
• To overcome the bottleneck of specialized detection instruments in resource-limited environments.

Main Methods:

• A portable fluorescence microarray imaging system, named "FluoroZen", was developed and connected to a smartphone.
• The system utilizes paper-based microfluidics for DNA hybridization assays, focusing on BRCA-1 detection from exon 11.
• Imaging is based on fluorescence microscopy principles, employing filters for excitation and emission spectra, with image acquisition via CCD cameras.

Main Results:

• The developed system successfully demonstrated DNA hybridization assay for breast cancer gene detection.
• FluoroZen provides a portable and effective method for acquiring microarray spot images.
• The smartphone-integrated platform shows potential for clinical translation in point-of-care testing.

Conclusions:

• A novel, portable, smartphone-based fluorescence microarray imaging system (FluoroZen) has been successfully developed.
• This system addresses the need for accessible microarray detection instruments, particularly in resource-limited settings.
• The technology holds promise for enabling point-of-care gene expression analysis, including breast cancer diagnostics, in clinical settings.